Peter Askovich
Makhortova NR, Askovich SP, Patterson CE, Gechman LA, Gerard NP, Rall GF. 2007. Neurokinin-1 enables measles virus trans-synaptic spread in neurons. Virology. 2007 May 25;362(1):235-44.
Fung KY, Askovic S, Basile F, Duncan MW. 2004 A simple and inexpensive approach to interfacing high-performance liquid chromatography and matrix-assisted laser desorption/ionization-time of flight-mass spectrometry. Proteomics. 4(10):3121-7.
Peltier J.M., Askovic S., Becklin R.R., Chepanoske C.L., Ho Y.J., Kery V., Lai S., Mujtaba T., Pyne M., Robbins P., von Rechenberg M., Richardson B., Savage J., Sheffield P., Thompson S., Weir L., Widjaja K., Xu N., Zhen Y., Boniface J.J. 2004. An integrated strategy for the discovery of drug targets by the analysis of protein-protein interactions. International Journal of Mass Spectrometry. 238:119-130
Dimcheff, D. E., Askovic, S. Baker, A. H., Johnson-Fowler, C., and Portis, J. L. 2003. Endoplasmic reticulum stress is a determinant of retrovirus-induced spongiform neurodegeneration. J Virol. 77(23):12617-29.
Evans C. F., Redwine J. M., Patterson C. E., Askovic S. and Rall G. F. 2002. LCMV and the Central Nervous System: Uncovering Basic Principles of CNS Physiology and Virus-Induced Disease. Curr Top Microbiol Immunol. 263:177-196.
Askovic S., McAtee F. J., Favara C. and Portis J. L. 2001. Increased expression of MIP-1 and MIP-1 mRNA in the brain correlates spatially and temporally with the spongiform neurodegeneration induced by a murine oncornavirus. J Virol. 75:2665-2674.
Askovic S., McAtee F. J., Favara C. and Portis J. L. 2000. Characterization of the brain infection by neuroinvasive, but avirulent murine oncornaviruses. J. Virol. 74:465-73.
Askovic S., Taylor W. and Baumann R. 1998. The Position of ZEBRA activation domain does not influence its biological activity. Virus Research. 57:125-138.
Askovic S. and Baumann R. 1997. Activation domain requirements for disruption of EBV latency by ZEBRA. J. Virol. 71:6547-6554.
Askovic S. and Baumann R. 1997. An alternative system for detecting and mapping activation domains. Biotechniques 22:948-951.
Baumann R., Warren G. and Askovic S. 1995. Restoration of the Epstein-Barr Virus ZEBRA protein's capacity to disrupt latency by the addition of heterologous activation regions. Virology 211:64-72